- Home
- TRSG vs TENX Comparison
TRSG vs TENX Comparison
Compare TRSG & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- TENX
- Stock Information
- Founded
- TRSG 1996
- TENX 1967
- Country
- TRSG Singapore
- TENX United States
- Employees
- TRSG N/A
- TENX N/A
- Industry
- TRSG
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- TRSG
- TENX Health Care
- Exchange
- TRSG NYSE
- TENX Nasdaq
- Market Cap
- TRSG 27.0M
- TENX 21.6M
- IPO Year
- TRSG 2024
- TENX N/A
- Fundamental
- Price
- TRSG $1.75
- TENX $6.05
- Analyst Decision
- TRSG
- TENX Strong Buy
- Analyst Count
- TRSG 0
- TENX 3
- Target Price
- TRSG N/A
- TENX $16.00
- AVG Volume (30 Days)
- TRSG 6.5K
- TENX 24.4K
- Earning Date
- TRSG 05-14-2025
- TENX 08-12-2025
- Dividend Yield
- TRSG N/A
- TENX N/A
- EPS Growth
- TRSG N/A
- TENX N/A
- EPS
- TRSG N/A
- TENX N/A
- Revenue
- TRSG $12,810,249.00
- TENX N/A
- Revenue This Year
- TRSG N/A
- TENX N/A
- Revenue Next Year
- TRSG N/A
- TENX N/A
- P/E Ratio
- TRSG N/A
- TENX N/A
- Revenue Growth
- TRSG N/A
- TENX N/A
- 52 Week Low
- TRSG $1.00
- TENX $2.80
- 52 Week High
- TRSG $4.57
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- TENX 57.60
- Support Level
- TRSG N/A
- TENX $5.77
- Resistance Level
- TRSG N/A
- TENX $6.19
- Average True Range (ATR)
- TRSG 0.00
- TENX 0.24
- MACD
- TRSG 0.00
- TENX 0.03
- Stochastic Oscillator
- TRSG 0.00
- TENX 72.33
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.